Vaccines
9 September 2013
Immunovaccine Reports Positive Results from Two Anthrax Studies6 September 2013
PaxVax Initiates Phase 3 Clinical Trial Challenge Studies for Single-Dose Oral Cholera Vaccine5 September 2013
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint5 September 2013
Apitope Announces Positive Results from Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis4 September 2013
Transgene Announces that its Phase 2 study of Pexa-Vec in Second-line Advanced Liver Cancer did not Meet its Primary Endpoint4 September 2013
Imaxio announces the first human clinical trial using its pro-immunogenic technology IMX313 in tuberculosis4 September 2013
Publication Demonstrates Superior Activity of ISA Pharmaceuticals´ SLP® Vaccines Compared to Whole Protein Vaccines29 August 2013
Pfizer Completes Pneumococcal Pneumonia Case Accrual For CAPiTA, Adult Vaccine Clinical Trial of Prevenar 1322 August 2013
Cellular Biomedicine Group Announces Completion of Patient Enrollment for Phase I Clinical Trial for Liver Cancer20 August 2013
Generex Announces Publication of Follow-up Studies from Phase I Trial of Novel Immunotherapeutic in Prostate Cancer Patients16 August 2013
Additional GlaxoSmithKline quadrivalent intramuscular influenza vaccine approved by FDA15 August 2013
Inovio Pharmaceuticals’ Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models13 August 2013
New Strategy to Disarm the Dengue Virus Brings New Hope for a Universal Dengue Vaccine5 August 2013
Sanofi Pasteur Initiates Phase III Study of Investigational Clostridium difficile Vaccine in the United StatesNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports